{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:58:42Z","timestamp":1793293122907,"version":"4.5.0"},"reference-count":151,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T00:00:00Z","timestamp":1731628800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10787-024-01595-9","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T10:34:49Z","timestamp":1731666889000},"page":"703-727","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pathophysiological role of high mobility group box-1 signaling in neurodegenerative diseases"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3615-9374","authenticated-orcid":false,"given":"Vishal","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7978-1043","authenticated-orcid":false,"given":"Puneet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,15]]},"reference":[{"key":"1595_CR1","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s00210-023-02512-7","volume":"396","author":"F Abbaszadeh","year":"2023","unstructured":"Abbaszadeh F, Jorjani M, Joghataei MT, Raminfard S, Mehrabi S (2023) Astaxanthin ameliorates spinal cord edema and astrocyte activation via suppression of HMGB1\/TLR4\/NF-\u03baB signaling pathway in a rat model of spinal cord injury. Naunyn Schmiedebergs Arch Pharmacol 396:3075\u20133086","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"1595_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.3390\/ph16101370","volume":"16","author":"MA Abd Elmaaboud","year":"2023","unstructured":"Abd Elmaaboud MA, Estfanous RS, Atef A, Kabel AM, Alnemari KA, Naguib TM, Alsufyani SE, Darwish HW, Arab HH (2023) Dapagliflozin\/hesperidin combination mitigates lipopolysaccharide-induced Alzheimer\u2019s disease in rats. Pharmaceuticals 16:1370","journal-title":"Pharmaceuticals"},{"key":"1595_CR3","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1021\/acschemneuro.2c00005","volume":"13","author":"IM Abdallah","year":"2022","unstructured":"Abdallah IM, Al-Shami KM, Yang E, Wang J, Guillaume C, Kaddoumi A (2022) Oleuropein-rich olive leaf extract attenuates neuroinflammation in the Alzheimer\u2019s disease mouse model. ACS Chem Neurosci 13:1002\u20131013","journal-title":"ACS Chem Neurosci"},{"key":"1595_CR4","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.3390\/molecules28031249","volume":"28","author":"IM Abdallah","year":"2023","unstructured":"Abdallah IM, Al-Shami KM, Alkhalifa AE, Al-Ghraiybah NF, Guillaume C, Kaddoumi A (2023) Comparison of oleocanthal-low EVOO and oleocanthal against amyloid-\u03b2 and related pathology in a mouse model of Alzheimer\u2019s disease. Molecules 28:1249","journal-title":"Molecules"},{"key":"1595_CR5","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00018-022-04372-5","volume":"79","author":"M Abeditashi","year":"2022","unstructured":"Abeditashi M, Weber JJ, Pereira Sena P, Velic A, Kalimeri M, Incebacak Eltemur RD, Schmidt J, H\u00fcbener-Schmid J, Hauser S, Macek B (2022) KPNB1 modulates the machado-Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP. Cell Mol Life Sci 79:401","journal-title":"Cell Mol Life Sci"},{"key":"1595_CR6","first-page":"082","volume":"4","author":"NH Aboelsoud","year":"2010","unstructured":"Aboelsoud NH (2010) Herbal medicine in ancient Egypt. J Med Plants Res 4:082\u2013086","journal-title":"J Med Plants Res"},{"key":"1595_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2021.119310","volume":"273","author":"SA Abuelezz","year":"2021","unstructured":"Abuelezz SA, Hendawy N (2021) HMGB1\/RAGE\/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis. Life Sci 273:119310","journal-title":"Life Sci"},{"key":"1595_CR8","doi-asserted-by":"publisher","first-page":"4781","DOI":"10.3390\/ijms22094781","volume":"22","author":"S Alabed","year":"2021","unstructured":"Alabed S, Zhou H, Sariyer IK, Chang SL (2021) Meta-analysis of methamphetamine modulation on amyloid precursor protein through HMGB1 in Alzheimer\u2019s disease. Int J Mol Sci 22:4781","journal-title":"Int J Mol Sci"},{"key":"1595_CR9","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","volume":"22","author":"U Andersson","year":"2018","unstructured":"Andersson U, Yang H, Harris H (2018) Extracellular HMGB1 as a therapeutic target in inflammatory diseases. Expert Opin Ther Targets 22:263\u2013277","journal-title":"Expert Opin Ther Targets"},{"key":"1595_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/978-81-322-2680-2_4","author":"W Ansar","year":"2016","unstructured":"Ansar W, Ghosh S, Ansar W, Ghosh S (2016) Inflammation and inflammatory diseases, markers, and mediators: role of CRP in some inflammatory diseases. Biol C React Protein Health Dis. https:\/\/doi.org\/10.1007\/978-81-322-2680-2_4","journal-title":"Biol C React Protein Health Dis"},{"key":"1595_CR11","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.3390\/cells11182908","volume":"11","author":"B Ara\u00fajo","year":"2022","unstructured":"Ara\u00fajo B, Caridade-Silva R, Soares-Guedes C, Martins-Macedo J, Gomes ED, Monteiro S, Teixeira FG (2022) Neuroinflammation and Parkinson\u2019s disease\u2014from neurodegeneration to therapeutic opportunities. Cells 11:2908","journal-title":"Cells"},{"key":"1595_CR12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong MJ, Okun MS (2020) Diagnosis and treatment of Parkinson disease: a review. JAMA 323:548\u2013560","journal-title":"JAMA"},{"key":"1595_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41598-020-80664-9","volume":"11","author":"M Asher","year":"2021","unstructured":"Asher M, Rosa J-G, Cvetanovic M (2021) Mood alterations in mouse models of Spinocerebellar Ataxia type 1. Sci Rep 11:713","journal-title":"Sci Rep"},{"key":"1595_CR14","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000487056","volume":"10","author":"H Aucott","year":"2018","unstructured":"Aucott H, Lundberg J, Salo H, Klevenvall L, Damberg P, Ottosson L, Andersson U, Holmin S, Erlandsson Harris H (2018) Neuroinflammation in response to intracerebral injections of different HMGB1 Redox Isoforms. J Innate Immun 10:215\u2013227","journal-title":"J Innate Immun"},{"key":"1595_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121049","volume":"311","author":"YO Azar","year":"2022","unstructured":"Azar YO, Badawi GA, Zaki HF, Ibrahim SM (2022) Agmatine-mediated inhibition of NMDA receptor expression and amelioration of dyskinesia via activation of Nrf2 and suppression of HMGB1\/RAGE\/TLR4\/MYD88\/NF-\u03baB signaling cascade in rotenone lesioned rats. Life Sci 311:121049","journal-title":"Life Sci"},{"key":"1595_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1159\/000494435","volume":"25","author":"V Bagheri","year":"2019","unstructured":"Bagheri V, Khorramdelazad H, Hassanshahi G, Moghadam-Ahmadi A, Vakilian A (2019) CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease. NeuroImmunoModulation 25:201\u2013205","journal-title":"NeuroImmunoModulation"},{"key":"1595_CR17","doi-asserted-by":"publisher","first-page":"170","DOI":"10.3389\/fnins.2012.00170","volume":"6","author":"CL Barberini","year":"2012","unstructured":"Barberini CL, Morrison SE, Saez A, Lau B, Salzman CD (2012) Complexity and competition in appetitive and aversive neural circuits. Front Neurosci 6:170","journal-title":"Front Neurosci"},{"key":"1595_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.dnarep.2016.10.006","volume":"48","author":"JM Beaver","year":"2016","unstructured":"Beaver JM, Lai Y, Rolle SJ, Liu Y (2016) Proliferating cell nuclear antigen prevents trinucleotide repeat expansions by promoting repeat deletion and hairpin removal. DNA Repair (Amst) 48:17\u201329","journal-title":"DNA Repair (Amst)"},{"key":"1595_CR19","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1021\/acs.jmedchem.7b00058","volume":"60","author":"S Bongarzone","year":"2017","unstructured":"Bongarzone S, Savickas V, Luzi F, Gee AD (2017) Targeting the receptor for advanced glycation endproducts (RAGE): a medicinal chemistry perspective. J Med Chem 60:7213\u20137232","journal-title":"J Med Chem"},{"key":"1595_CR20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s13311-018-00696-y","volume":"16","author":"RA Buijsen","year":"2019","unstructured":"Buijsen RA, Toonen LJ, Gardiner SL, van Roon-Mom WM (2019) Genetics, mechanisms, and therapeutic progress in polyglutamine spinocerebellar ataxias. Neurotherapeutics 16:263\u2013286","journal-title":"Neurotherapeutics"},{"key":"1595_CR21","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1007\/s11011-022-00932-7","volume":"37","author":"W Chai","year":"2022","unstructured":"Chai W, Zhang J, Xiang Z, Zhang H, Mei Z, Nie H, Xu R, Zhang P (2022) Potential of nobiletin against Alzheimer\u2019s disease through inhibiting neuroinflammation. Metab Brain Dis 37:1145\u20131154","journal-title":"Metab Brain Dis"},{"key":"1595_CR22","doi-asserted-by":"publisher","first-page":"101144","DOI":"10.1016\/j.jbc.2021.101144","volume":"297","author":"KY Chan","year":"2021","unstructured":"Chan KY, Li X, Ortega J, Gu L, Li G-M (2021) DNA polymerase \u03b8 promotes CAG\u2022 CTG repeat expansions in Huntington\u2019s disease via insertion sequences of its catalytic domain. J Biol Chem 297:101144","journal-title":"J Biol Chem"},{"key":"1595_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12974-023-02853-3","volume":"20","author":"Y Chen","year":"2023","unstructured":"Chen Y, Yu Y (2023) Tau and neuroinflammation in Alzheimer\u2019s disease: interplay mechanisms and clinical translation. J Neuroinflammation 20:165","journal-title":"J Neuroinflammation"},{"key":"1595_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00736-w","volume":"13","author":"Y Chen","year":"2021","unstructured":"Chen Y, Zhao S, Fan Z, Li Z, Zhu Y, Shen T, Li K, Yan Y, Tian J, Liu Z (2021) Metformin attenuates plaque-associated tau pathology and reduces amyloid-\u03b2 burden in APP\/PS1 mice. Alzheimer\u2019s Res & Ther 13:1\u201313","journal-title":"Alzheimer\u2019s Res & Ther"},{"key":"1595_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s12276-022-00736-w","volume":"54","author":"R Chen","year":"2022","unstructured":"Chen R, Kang R, Tang D (2022) The mechanism of HMGB1 secretion and release. Exp Mol Med 54:91\u2013102","journal-title":"Exp Mol Med"},{"key":"1595_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s12031-020-01699-1","volume":"71","author":"E Chibaatar","year":"2021","unstructured":"Chibaatar E, Le K, Abdoulaye IA, Wu S, Guo Y (2021) Melatonin ameliorates lipopolysaccharide-induced microglial inflammation via triggering SIRT1\/HMGB1 signaling axis. J Mol Neurosci 71:691\u2013701","journal-title":"J Mol Neurosci"},{"key":"1595_CR27","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41598-022-04955-z","volume":"12","author":"K-L Chin","year":"2022","unstructured":"Chin K-L, Zainal N, Sam S-S, Hassandarvish P, Lani R, AbuBakar S (2022) Intracellular translocation of HMGB1 is important for Zika virus replication in Huh7 cells. Sci Rep 12:1054","journal-title":"Sci Rep"},{"key":"1595_CR28","doi-asserted-by":"publisher","first-page":"526","DOI":"10.2119\/molmed.2015.00148","volume":"21","author":"HW Choi","year":"2015","unstructured":"Choi HW, Tian M, Song F, Venereau E, Preti A, Park S-W, Hamilton K, Swapna G, Manohar M, Moreau M (2015) Aspirin\u2019s active metabolite salicylic acid targets high mobility group box 1 to modulate inflammatory responses. Mol Med 21:526\u2013535","journal-title":"Mol Med"},{"key":"1595_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41598-018-36912-0","volume":"9","author":"A Corti","year":"2019","unstructured":"Corti A, Sota R, Dugo M, Calogero RA, Terragni B, Mantegazza M, Franceschetti S, Restelli M, Gasparini P, Lecis D (2019) DNA damage and transcriptional regulation in iPSC-derived neurons from Ataxia Telangiectasia patients. Sci Rep 9:651","journal-title":"Sci Rep"},{"key":"1595_CR30","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/antiox12030571","volume":"12","author":"F D\u2019Egidio","year":"2023","unstructured":"D\u2019Egidio F, Castelli V, Cimini A, d\u2019Angelo M (2023) Cell rearrangement and oxidant\/antioxidant imbalance in Huntington\u2019s disease. Antioxidants 12:571","journal-title":"Antioxidants"},{"key":"1595_CR31","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1517\/13543776.2011.636354","volume":"21","author":"D Ekinci","year":"2011","unstructured":"Ekinci D, \u015eent\u00fcrk M, K\u00fcfrevio\u011flu \u00d6\u0130 (2011) Salicylic acid derivatives: synthesis, features and usage as therapeutic tools. Expert Opin Ther Pat 21:1831\u20131841","journal-title":"Expert Opin Ther Pat"},{"key":"1595_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203837","volume":"13","author":"H El-Abhar","year":"2018","unstructured":"El-Abhar H, Abd El Fattah MA, Wadie W, El-Tanbouly DM (2018) Cilostazol disrupts TLR-4, Akt\/GSK-3\u03b2\/CREB, and IL-6\/JAK-2\/STAT-3\/SOCS-3 crosstalk in a rat model of Huntington\u2019s disease. PLoS\u00a0One 13:e0203837","journal-title":"PLoS\u00a0One"},{"key":"1595_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.109986","volume":"117","author":"RM El-Sayed","year":"2023","unstructured":"El-Sayed RM, Abdelaziz AM, Zaki HF, Rasheed NOA (2023) Cilostazol novel neuroprotective mechanism against rotenone-induced Parkinson\u2019s disease in rats: correlation between Nrf2 and HMGB1\/TLR4\/PI3K\/Akt\/mTOR signaling. Int Immunopharmacol 117:109986","journal-title":"Int Immunopharmacol"},{"key":"1595_CR34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1159\/000524732","volume":"56","author":"A Exuzides","year":"2022","unstructured":"Exuzides A, Reddy SR, Chang E, Ta JT, Patel AM, Paydar C, Yohrling GJ (2022) Epidemiology of Huntington\u2019s disease in the United States medicare and medicaid populations. Neuroepidemiology 56:192\u2013200","journal-title":"Neuroepidemiology"},{"key":"1595_CR35","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1021\/acschemneuro.6b00250","volume":"8","author":"AS Falcao","year":"2017","unstructured":"Falcao AS, Carvalho LA, Lidonio G, Vaz AR, Lucas SD, Moreira R, Brites D (2017) Dipeptidyl vinyl sulfone as a novel chemical tool to inhibit HMGB1\/NLRP3-inflammasome and inflamma-miRs in A\u03b2-mediated microglial inflammation. ACS Chem Neurosci 8:89\u201399","journal-title":"ACS Chem Neurosci"},{"key":"1595_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/sj.onc.1209021","volume":"25","author":"Z Feng","year":"2006","unstructured":"Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ (2006) p53 tumor suppressor protein regulates the levels of Huntingtin gene expression. Oncogene 25:1\u20137","journal-title":"Oncogene"},{"key":"1595_CR37","doi-asserted-by":"publisher","first-page":"117957352210925","DOI":"10.1177\/11795735221092517","volume":"14","author":"MW Ferguson","year":"2022","unstructured":"Ferguson MW, Kennedy CJ, Palpagama TH, Waldvogel HJ, Faull RL, Kwakowsky A (2022) Current and possible future therapeutic options for Huntington\u2019s disease. J Cent Nerv Syst Dis 14:11795735221092516","journal-title":"J Cent Nerv Syst Dis"},{"key":"1595_CR38","doi-asserted-by":"publisher","first-page":"31895","DOI":"10.1038\/srep31895","volume":"6","author":"K Fujita","year":"2016","unstructured":"Fujita K, Motoki K, Tagawa K, Chen X, Hama H, Nakajima K, Homma H, Tamura T, Watanabe H, Katsuno M (2016) HMGB1, a pathogenic molecule that induces neurite degeneration via TLR4-MARCKS, is a potential therapeutic target for Alzheimer\u2019s disease. Sci Rep 6:31895","journal-title":"Sci Rep"},{"key":"1595_CR39","doi-asserted-by":"publisher","first-page":"109419","DOI":"10.1016\/j.celrep.2021.109419","volume":"36","author":"S Gaikwad","year":"2021","unstructured":"Gaikwad S, Puangmalai N, Bittar A, Montalbano M, Garcia S, McAllen S, Bhatt N, Sonawane M, Sengupta U, Kayed R (2021) Tau oligomer induced HMGB1 release contributes to cellular senescence and neuropathology linked to Alzheimer\u2019s disease and frontotemporal dementia. Cell Rep 36:109419","journal-title":"Cell Rep"},{"key":"1595_CR40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3389\/fphar.2020.00776","volume":"11","author":"P Gan","year":"2020","unstructured":"Gan P, Ding L, Hang G, Xia Q, Huang Z, Ye X, Qian X (2020) Oxymatrine attenuates dopaminergic neuronal damage and microglia-mediated neuroinflammation through cathepsin D-dependent HMGB1\/TLR4\/NF-\u03baB pathway in Parkinson\u2019s disease. Front Pharmacol 11:776","journal-title":"Front Pharmacol"},{"key":"1595_CR41","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1523\/JNEUROSCI.3732-10.2011","volume":"31","author":"H-M Gao","year":"2011","unstructured":"Gao H-M, Zhou H, Zhang F, Wilson BC, Kam W, Hong J-S (2011) HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration. J Neurosci 31:1081\u20131092","journal-title":"J Neurosci"},{"key":"1595_CR42","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1038\/s41401-022-00888-5","volume":"43","author":"J-m Gao","year":"2022","unstructured":"Gao J-m, Zhang X, Shu G-t, Chen N-n, Zhang J-y, Xu F, Li F, Liu Y-g, Wei Y, He Y-q (2022) Trilobatin rescues cognitive impairment of Alzheimer\u2019s disease by targeting HMGB1 through mediating SIRT3\/SOD2 signaling pathway. Acta Pharmacol Sin 43:2482\u20132494","journal-title":"Acta Pharmacol Sin"},{"key":"1595_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121317","volume":"314","author":"AM Gendy","year":"2023","unstructured":"Gendy AM, El-Sadek HM, Amin MM, Ahmed KA, El-Sayed MK, El-Haddad AE, Soubh A (2023) Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1\/TLR4\/NF-\u03baB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats. Life Sci 314:121317","journal-title":"Life Sci"},{"key":"1595_CR44","doi-asserted-by":"publisher","first-page":"e00508","DOI":"10.1016\/j.heliyon.2018.e00508","volume":"4","author":"K Griffioen","year":"2018","unstructured":"Griffioen K, Mattson MP, Okun E (2018) Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington\u2019s disease mice. Heliyon 4:e00508","journal-title":"Heliyon"},{"key":"1595_CR45","doi-asserted-by":"publisher","first-page":"5481","DOI":"10.1038\/s41380-021-01249-0","volume":"26","author":"H Hampel","year":"2021","unstructured":"Hampel H, Hardy J, Blennow K, Chen C, Perry G, Kim SH, Villemagne VL, Aisen P, Vendruscolo M, Iwatsubo T (2021) The amyloid-\u03b2 pathway in Alzheimer\u2019s disease. Mol Psychiatry 26:5481\u20135503","journal-title":"Mol Psychiatry"},{"key":"1595_CR46","doi-asserted-by":"publisher","first-page":"8947","DOI":"10.1111\/jcmm.16855","volume":"25","author":"Y Han","year":"2021","unstructured":"Han Y, Chen R, Lin Q, Liu Y, Ge W, Cao H, Li J (2021) Curcumin improves memory deficits by inhibiting HMGB1-RAGE\/TLR4-NF-\u03baB signalling pathway in APPswe\/PS1dE9 transgenic mice hippocampus. J Cell Mol Med 25:8947\u20138956","journal-title":"J Cell Mol Med"},{"key":"1595_CR47","doi-asserted-by":"publisher","first-page":"6481","DOI":"10.1007\/s11033-023-08561-8","volume":"50","author":"C Han","year":"2023","unstructured":"Han C, Zhang X, Dou K, Yao W, Yao M, Wan Q, Xie A (2023) Repetitive transcranial magnetic stimulation alleviates glial activation through suppressing HMGB1\/TLR4 pathway in a rat model of Parkinson\u2019s disease. Mol Biol Rep 50:6481\u20136492","journal-title":"Mol Biol Rep"},{"key":"1595_CR48","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.expneurol.2017.11.010","volume":"300","author":"AS Harms","year":"2018","unstructured":"Harms AS, Thome AD, Yan Z, Schonhoff AM, Williams GP, Li X, Liu Y, Qin H, Benveniste EN, Standaert DG (2018) Peripheral monocyte entry is required for alpha-Synuclein induced inflammation and Neurodegeneration in a model of Parkinson disease. Exp Neurol 300:179\u2013187","journal-title":"Exp Neurol"},{"key":"1595_CR49","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s12640-019-00148-1","volume":"37","author":"M Huang","year":"2020","unstructured":"Huang M, Guo M, Wang K, Wu K, Li Y, Tian T, Wang Y, Yan W, Zhou Z, Yang H (2020) HMGB1 mediates paraquat-induced neuroinflammatory responses via activating RAGE signaling pathway. Neurotox Res 37:913\u2013925","journal-title":"Neurotox Res"},{"key":"1595_CR50","doi-asserted-by":"publisher","first-page":"2237209","DOI":"10.1080\/14756366.2023.2237209","volume":"38","author":"X Huang","year":"2023","unstructured":"Huang X, You L, Nepovimova E, Psotka M, Malinak D, Valko M, Sivak L, Korabecny J, Heger Z, Adam V (2023) Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK). J Enzyme Inhib Med Chem 38:2237209","journal-title":"J Enzyme Inhib Med Chem"},{"key":"1595_CR51","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/brainsci12101389","volume":"12","author":"Z Irfan","year":"2022","unstructured":"Irfan Z, Khanam S, Karmakar V, Firdous SM, El Khier BSIA, Khan I, Rehman MU, Khan A (2022) Pathogenesis of Huntington\u2019s disease: an emphasis on molecular pathways and prevention by natural remedies. Brain Sci 12:1389","journal-title":"Brain Sci"},{"key":"1595_CR52","doi-asserted-by":"publisher","first-page":"78","DOI":"10.15252\/emmm.201404392","volume":"7","author":"H Ito","year":"2015","unstructured":"Ito H, Fujita K, Tagawa K, Chen X, Homma H, Sasabe T, Shimizu J, Shimizu S, Tamura T, Si M (2015) HMGB 1 facilitates repair of mitochondrial DNA damage and extends the lifespan of mutant ataxin-1 knock-in mice. EMBO Mol Med 7:78\u2013101","journal-title":"EMBO Mol Med"},{"key":"1595_CR53","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062235","volume":"8","author":"V Jain","year":"2013","unstructured":"Jain V, Baitharu I, Prasad D, Ilavazhagan G (2013) Enriched environment prevents hypobaric hypoxia induced memory impairment and neurodegeneration: role of BDNF\/PI3K\/GSK3\u03b2 pathway coupled with CREB activation. PLoS\u00a0One 8:e62235","journal-title":"PLoS\u00a0One"},{"key":"1595_CR54","doi-asserted-by":"publisher","first-page":"6782872","DOI":"10.1155\/2020\/6782872","volume":"2020","author":"F Jiao","year":"2020","unstructured":"Jiao F, Gong Z (2020) The beneficial roles of SIRT1 in neuroinflammation-related diseases. Oxid Med Cell Longev 2020:6782872","journal-title":"Oxid Med Cell Longev"},{"key":"1595_CR55","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.3390\/biomedicines10061432","volume":"10","author":"A Jurcau","year":"2022","unstructured":"Jurcau A (2022) Molecular pathophysiological mechanisms in Huntington\u2019s disease. Biomedicines 10:1432","journal-title":"Biomedicines"},{"key":"1595_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mam.2014.05.001","volume":"40","author":"R Kang","year":"2014","unstructured":"Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, Zeh HJ 3rd, Lotze MT, Tang D (2014) HMGB1 in health and disease. Mol Aspects Med 40:1\u2013116","journal-title":"Mol Aspects Med"},{"key":"1595_CR57","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.2741\/2802","volume":"13","author":"R Kapadia","year":"2008","unstructured":"Kapadia R, Yi J-H, Vemuganti R (2008) Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists. Front Biosci 13:1813","journal-title":"Front Biosci"},{"key":"1595_CR58","doi-asserted-by":"publisher","first-page":"5314","DOI":"10.3390\/ijms20215314","volume":"20","author":"B Khambu","year":"2019","unstructured":"Khambu B, Yan S, Huda N, Yin XM (2019) Role of high-mobility group box-1 in liver pathogenesis. Int J Mol Sci 20:5314","journal-title":"Int J Mol Sci"},{"key":"1595_CR59","doi-asserted-by":"publisher","first-page":"7999","DOI":"10.1523\/JNEUROSCI.2675-04.2004","volume":"24","author":"A Khoshnan","year":"2004","unstructured":"Khoshnan A, Ko J, Watkin EE, Paige LA, Reinhart PH, Patterson PH (2004) Activation of the I\u03baB kinase complex and nuclear factor-\u03baB contributes to mutant Huntingtin neurotoxicity. J Neurosci 24:7999\u20138008","journal-title":"J Neurosci"},{"key":"1595_CR60","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/jnc.13178","volume":"134","author":"J Kim","year":"2015","unstructured":"Kim J, Waldvogel HJ, Faull RL, Curtis MA, Nicholson LF (2015) The RAGE receptor and its ligands are highly expressed in astrocytes in a grade-dependant manner in the striatum and subependymal layer in Huntington\u2019s disease. J Neurochem 134:927\u2013942","journal-title":"J Neurochem"},{"key":"1595_CR61","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.bbrc.2017.09.017","volume":"493","author":"SJ Kim","year":"2017","unstructured":"Kim SJ, Ryu MJ, Han J, Jang Y, Kim J, Lee MJ, Ryu I, Ju X, Oh E, Chung W (2017) Activation of the HMGB1-RAGE axis upregulates TH expression in dopaminergic neurons via JNK phosphorylation. Biochem Biophys Res Commun 493:358\u2013364","journal-title":"Biochem Biophys Res Commun"},{"key":"1595_CR62","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s12031-017-0989-7","volume":"63","author":"Z-H Kong","year":"2017","unstructured":"Kong Z-H, Chen X, Hua H-P, Liang L, Liu L-J (2017) The oral pretreatment of glycyrrhizin prevents surgery-induced cognitive impairment in aged mice by reducing neuroinflammation and Alzheimer\u2019s-related pathology via HMGB1 inhibition. J Mol Neurosci 63:385\u2013395","journal-title":"J Mol Neurosci"},{"key":"1595_CR63","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2174\/1874467214666210126113324","volume":"14","author":"S Kumar","year":"2021","unstructured":"Kumar S, Kumar P (2021) The beneficial effect of rice bran extract against rotenone-induced experimental Parkinson\u2019s disease in rats. Curr Mol Pharmacol 14:428\u2013438","journal-title":"Curr Mol Pharmacol"},{"key":"1595_CR64","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.pharep.2014.09.004","volume":"67","author":"A Kumar","year":"2015","unstructured":"Kumar A, SinghEkavali A (2015) A review on Alzheimer\u2019s disease pathophysiology and its management: an update. Pharmacol Rep 67:195\u2013203","journal-title":"Pharmacol Rep"},{"key":"1595_CR65","doi-asserted-by":"publisher","first-page":"8181","DOI":"10.1007\/s11033-021-06787-y","volume":"48","author":"V Kumar","year":"2021","unstructured":"Kumar V, Singh C, Singh A (2021) Zebrafish an experimental model of Huntington\u2019s disease: Molecular aspects, therapeutic targets and current challenges. Mol Biol Rep 48:8181\u20138194","journal-title":"Mol Biol Rep"},{"key":"1595_CR66","doi-asserted-by":"publisher","first-page":"158","DOI":"10.2174\/1570159X19666210609160017","volume":"20","author":"V Kumar","year":"2022","unstructured":"Kumar V, Kundu S, Singh A, Singh S (2022a) Understanding the role of histone deacetylase and their inhibitors in neurodegenerative disorders: current targets and future perspective. Curr Neuropharmacol 20:158\u2013178","journal-title":"Curr Neuropharmacol"},{"key":"1595_CR67","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1089\/rej.2022.0036","volume":"25","author":"V Kumar","year":"2022","unstructured":"Kumar V, Singh C, Singh A (2022b) Neuroprotective potential of hydroalcoholic extract of Centella asiatica against 3-nitropropionic acid-induced Huntington\u2019s like symptoms in adult zebrafish. Rejuvenation Res 25:260\u2013274","journal-title":"Rejuvenation Res"},{"key":"1595_CR68","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.3389\/fimmu.2020.01189","volume":"11","author":"MS Kwak","year":"2020","unstructured":"Kwak MS, Kim HS, Lee B, Kim YH, Son M, Shin J-S (2020) Immunological significance of HMGB1 post-translational modification and redox biology. Front Immunol 11:1189","journal-title":"Front Immunol"},{"key":"1595_CR69","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s40035-020-00221-2","volume":"9","author":"HS Kwon","year":"2020","unstructured":"Kwon HS, Koh SH (2020) Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes. Transl Neurodegener 9:42","journal-title":"Transl Neurodegener"},{"key":"1595_CR70","doi-asserted-by":"publisher","first-page":"fcaa066","DOI":"10.1093\/braincomms\/fcaa066","volume":"2","author":"C Landles","year":"2020","unstructured":"Landles C, Milton RE, Ali N, Flomen R, Flower M, Schindler F, Gomez-Paredes C, Bondulich MK, Osborne GF, Goodwin D (2020) Subcellular localization and formation of Huntingtin aggregates correlates with symptom onset and progression in a Huntington\u2019s disease model. Brain Commun 2:fcaa066","journal-title":"Brain Commun"},{"key":"1595_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002270","volume":"14","author":"H-M Lanoisel\u00e9e","year":"2017","unstructured":"Lanoisel\u00e9e H-M, Nicolas G, Wallon D, Rovelet-Lecrux A, Lacour M, Rousseau S, Richard A-C, Pasquier F, Rollin-Sillaire A, Martinaud O (2017) APP, PSEN1, and PSEN2 mutations in early-onset Alzheimer disease: a genetic screening study of familial and sporadic cases. PLoS Med 14:e1002270","journal-title":"PLoS Med"},{"key":"1595_CR72","doi-asserted-by":"publisher","first-page":"6923","DOI":"10.3390\/ijms23136923","volume":"23","author":"A Leathem","year":"2022","unstructured":"Leathem A, Ortiz-Cerda T, Dennis JM, Witting PK (2022) Evidence for oxidative pathways in the pathogenesis of PD: are antioxidants candidate drugs to ameliorate disease progression? Int J Mol Sci 23:6923","journal-title":"Int J Mol Sci"},{"key":"1595_CR73","doi-asserted-by":"publisher","DOI":"10.1101\/2024.05.10.593545","author":"M Lebouc","year":"2024","unstructured":"Lebouc M, Bonamy L, Scharnholz J, Richard Q, Courtand G, Baufreton JM, Garret M (2024) Developmental alterations of indirect-pathway medium spiny neurons in mouse models of Huntington\u2019s disease. bioRxiv. https:\/\/doi.org\/10.1101\/2024.05.10.593545","journal-title":"bioRxiv"},{"key":"1595_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neulet.2008.08.053","volume":"445","author":"Z Li","year":"2008","unstructured":"Li Z, Choi D-Y, Shin E-J, Hunter RL, Jin CH, Wie M-B, Kim MS, Park SJ, Bing G, Kim H-C (2008) Phenidone protects the nigral dopaminergic neurons from LPS-induced neurotoxicity. Neurosci Lett 445:1\u20136","journal-title":"Neurosci Lett"},{"key":"1595_CR75","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12974-019-1646-6","volume":"16","author":"Y Li","year":"2019","unstructured":"Li Y, Niu M, Zhao A, Kang W, Chen Z, Luo N, Zhou L, Zhu X, Lu L, Liu J (2019) CXCL12 is involved in \u03b1-synuclein-triggered neuroinflammation of Parkinson\u2019s disease. J Neuroinflammation 16:1\u201314","journal-title":"J Neuroinflammation"},{"key":"1595_CR76","doi-asserted-by":"publisher","first-page":"4751349","DOI":"10.1155\/2020\/4751349","volume":"2020","author":"Y Li","year":"2020","unstructured":"Li Y, Liu T, Li Y, Han D, Hong J, Yang N, He J, Peng R, Mi X, Kuang C, Zhou Y, Han Y, Shi C, Li Z, Guo X (2020) Baicalin ameliorates cognitive impairment and protects microglia from LPS-induced neuroinflammation via the SIRT1\/HMGB1 pathway. Oxid Med Cell Longev 2020:4751349","journal-title":"Oxid Med Cell Longev"},{"key":"1595_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106379","volume":"190","author":"K Liang","year":"2024","unstructured":"Liang K, Li X, Guo Q, Ma J, Yang H, Fan Y, Yang D, Shi X, She Z, Qi X, Gu Q, Chen S, Zheng J, Li D (2024a) Structural changes in the retina and serum HMGB1 levels are associated with decreased cognitive function in patients with Parkinson\u2019s disease. Neurobiol Dis 190:106379","journal-title":"Neurobiol Dis"},{"key":"1595_CR78","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1007\/s12035-023-03668-2","volume":"61","author":"T Liang","year":"2024","unstructured":"Liang T, Yang S-X, Qian C, Du L-D, Qian Z-M, Yung W-H, Ke Y (2024b) HMGB1 mediates inflammation-induced DMT1 increase and dopaminergic neurodegeneration in the early stage of Parkinsonism. Mol Neurobiol 61:2006\u20132020","journal-title":"Mol Neurobiol"},{"key":"1595_CR79","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1111\/jnc.15368","volume":"158","author":"F Lin","year":"2021","unstructured":"Lin F, Shan W, Zheng Y, Pan L, Zuo Z (2021) Toll-like receptor 2 activation and up-regulation by high mobility group box-1 contribute to post-operative neuroinflammation and cognitive dysfunction in mice. J Neurochem 158:328\u2013341","journal-title":"J Neurochem"},{"key":"1595_CR80","doi-asserted-by":"publisher","first-page":"8387636","DOI":"10.1155\/2019\/8387636","volume":"2019","author":"K Liu","year":"2019","unstructured":"Liu K, Li M, Ren X, You Q-s, Wang F, Wang S, Ma C-H, Li W-N, Ye Q (2019) Huang qi tong bi decoction attenuates myocardial ischemia-reperfusion injury via HMGB1\/TLR\/NF-\u03baB pathway. Mediators Inflamm 2019:8387636","journal-title":"Mediators Inflamm"},{"key":"1595_CR81","first-page":"5521519","volume":"2021","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang B, Liu J, Qiao C, Xue N, Lv H, Li S (2021) Mogroside V alleviates lipopolysaccharide-induced neuroinflammation via inhibition of TLR4-MyD88 and activation of AKT\/AMPK-Nrf2 signaling pathway. Evid Based Complement Alternat Med 2021:5521519","journal-title":"Evid Based Complement Alternat Med"},{"key":"1595_CR82","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/WNR.0000000000001997","volume":"35","author":"L Liu","year":"2024","unstructured":"Liu L, Jiang L, Zhang J, Ma Y, Wan M, Hu X, Yang L (2024) Imperatorin inhibits oxidative stress injury and neuroinflammation via the PI3K\/AKT signaling pathway in the MPTP-induced Parkinson\u2019s disease mouse. NeuroReport 35:175\u2013184","journal-title":"NeuroReport"},{"key":"1595_CR83","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3010523","author":"X-H Lu","year":"2014","unstructured":"Lu X-H, Mattis VB, Wang N, Al-Ramahi I, van den Berg N, Fratantoni SA, Waldvogel H, Greiner E, Osmand A, Elzein K (2014) Targeting ATM ameliorates mutant Huntingtin toxicity in cell and animal models of Huntington\u2019s disease. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.3010523","journal-title":"Sci Transl Med"},{"key":"1595_CR84","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.lfs.2019.03.030","volume":"223","author":"R Lv","year":"2019","unstructured":"Lv R, Du L, Liu X, Zhou F, Zhang Z, Zhang L (2019) Rosmarinic acid attenuates inflammatory responses through inhibiting HMGB1\/TLR4\/NF-\u03baB signaling pathway in a mouse model of Parkinson\u2019s disease. Life Sci 223:158\u2013165","journal-title":"Life Sci"},{"key":"1595_CR85","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.brainres.2004.05.052","volume":"1018","author":"L Ma","year":"2004","unstructured":"Ma L, Nicholson LF (2004) Expression of the receptor for advanced glycation end products in Huntington\u2019s disease caudate nucleus. Brain Res 1018:10\u201317","journal-title":"Brain Res"},{"key":"1595_CR86","doi-asserted-by":"publisher","first-page":"18287","DOI":"10.18632\/aging.203274","volume":"13","author":"X Ma","year":"2021","unstructured":"Ma X, Song M, Yan Y, Ren G, Hou J, Qin G, Wang W, Li Z (2021) Albiflorin alleviates cognitive dysfunction in STZ-induced rats. Aging (Albany NY) 13:18287\u201318297","journal-title":"Aging (Albany NY)"},{"key":"1595_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.dnarep.2019.102701","volume":"83","author":"P Mandke","year":"2019","unstructured":"Mandke P, Vasquez KM (2019) Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses. DNA Repair 83:102701","journal-title":"DNA Repair"},{"key":"1595_CR88","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1038\/s41467-024-45505-7","volume":"15","author":"MV Mantonico","year":"2024","unstructured":"Mantonico MV, De Leo F, Quilici G, Colley LS, De Marchis F, Crippa M, Mezzapelle R, Schulte T, Zucchelli C, Pastorello C (2024) The acidic intrinsically disordered region of the inflammatory mediator HMGB1 mediates fuzzy interactions with CXCL12. Nat Commun 15:1201","journal-title":"Nat Commun"},{"key":"1595_CR89","doi-asserted-by":"publisher","first-page":"1029891","DOI":"10.3389\/fneur.2022.1029891","volume":"13","author":"D Mao","year":"2022","unstructured":"Mao D, Zheng Y, Xu F, Han X, Zhao H (2022) HMGB1 in nervous system diseases: a common biomarker and potential therapeutic target. Front Neurol 13:1029891","journal-title":"Front Neurol"},{"key":"1595_CR90","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1093\/hmg\/ddq358","volume":"19","author":"E Marcora","year":"2010","unstructured":"Marcora E, Kennedy MB (2010) The Huntington\u2019s disease mutation impairs Huntingtin\u2019s role in the transport of NF-\u03baB from the synapse to the nucleus. Hum Mol Genet 19:4373\u20134384","journal-title":"Hum Mol Genet"},{"key":"1595_CR91","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3233\/JHD-190391","volume":"9","author":"A McGarry","year":"2020","unstructured":"McGarry A, McDermott MP, Kieburtz K, Peng J, Cudkowicz M (2020) Baseline variables associated with functional decline in 2CARE, a randomized clinical trial in Huntington\u2019s disease. J Huntington\u2019s Dis 9:47\u201358","journal-title":"J Huntington\u2019s Dis"},{"key":"1595_CR92","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.4049\/jimmunol.1202472","volume":"190","author":"HJ Min","year":"2013","unstructured":"Min HJ, Ko EA, Wu J, Kim ES, Kwon MK, Kwak MS, Choi JE, Lee JE, Shin JS (2013) Chaperone-like activity of high-mobility group box 1 protein and its role in reducing the formation of polyglutamine aggregates. J Immunol 190:1797\u20131806","journal-title":"J Immunol"},{"key":"1595_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114541","volume":"161","author":"J Mo","year":"2023","unstructured":"Mo J, Hu J, Cheng X (2023) The role of high mobility group box 1 in neuroinflammatory related diseases. Biomed Pharmacother 161:114541","journal-title":"Biomed Pharmacother"},{"key":"1595_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109571","volume":"114","author":"YT Mohamed","year":"2023","unstructured":"Mohamed YT, Salama A, Rabie MA, Abd El Fattah MA (2023) Neuroprotective effect of secukinumab against rotenone induced Parkinson\u2019s disease in rat model: Involvement of IL-17, HMGB-1\/TLR4 axis and BDNF\/TrKB cascade. Int Immunopharmacol 114:109571","journal-title":"Int Immunopharmacol"},{"key":"1595_CR95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1515\/nipt-2023-0026","volume":"3","author":"S Mondal","year":"2024","unstructured":"Mondal S, Prieto S, Rangasamy SB, Dutta D, Pahan K (2024) Nebulization of low-dose aspirin ameliorates Huntington\u2019s pathology in N171\u201382Q transgenic mice. Neuroimmune Pharm Ther 3:47\u201359","journal-title":"Neuroimmune Pharm Ther"},{"key":"1595_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R (2023) Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol 211:115522","journal-title":"Biochem Pharmacol"},{"key":"1595_CR97","doi-asserted-by":"publisher","DOI":"10.1007\/s12035-024-03959-2","author":"S Mu","year":"2024","unstructured":"Mu S, Li Z, Lin L, Wang D, Yang F, Chen L, Xian L, Lin K, Lin Y, Ye D (2024) SIRT1-mediated HMGB1 deacetylation suppresses neutrophil extracellular traps related to blood-brain barrier impairment after cerebral venous thrombosis. Mol Neurobiol. https:\/\/doi.org\/10.1007\/s12035-024-03959-2","journal-title":"Mol Neurobiol"},{"key":"1595_CR98","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.intimp.2018.12.027","volume":"67","author":"K Nan","year":"2019","unstructured":"Nan K, Han Y, Fang Q, Huang C, Yu L, Ge W, Xiang F, Tao Y-X, Cao H, Li J (2019) HMGB1 gene silencing inhibits neuroinflammation via down-regulation of NF-\u03baB signaling in primary hippocampal neurons induced by A\u03b225\u201335. Int Immunopharmacol 67:294\u2013301","journal-title":"Int Immunopharmacol"},{"key":"1595_CR99","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.neulet.2007.09.056","volume":"434","author":"M Napolitano","year":"2008","unstructured":"Napolitano M, Zei D, Centonze D, Palermo R, Bernardi G, Vacca A, Calabresi P, Gulino A (2008) NF-kB\/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington\u2019s disease. Neurosci Lett 434:241\u2013246","journal-title":"Neurosci Lett"},{"key":"1595_CR100","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41420-020-00293-z","volume":"6","author":"E Paldino","year":"2020","unstructured":"Paldino E, D\u2019Angelo V, Sancesario G, Fusco FR (2020) Pyroptotic cell death in the R6\/2 mouse model of Huntington\u2019s disease: new insight on the inflammasome. Cell Death Discovery 6:69","journal-title":"Cell Death Discovery"},{"key":"1595_CR101","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3390\/cells9020383","volume":"9","author":"YN Paudel","year":"2020","unstructured":"Paudel YN, Angelopoulou E, Piperi C, Othman I, Aamir K, Shaikh MF (2020) Impact of HMGB1, RAGE, and TLR4 in Alzheimer\u2019s disease (AD): from risk factors to therapeutic targeting. Cells 9:383","journal-title":"Cells"},{"key":"1595_CR102","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113681","volume":"171","author":"MA Rabie","year":"2020","unstructured":"Rabie MA, Abd El Fattah MA, Nassar NN, Abdallah DM, El-Abhar HS (2020) Correlation between angiotensin 1\u20137-mediated Mas receptor expression with motor improvement, activated STAT3\/SOCS3 cascade, and suppressed HMGB-1\/RAGE\/NF-\u03baB signaling in 6-hydroxydopamine hemiparkinsonian rats. Biochem Pharmacol 171:113681","journal-title":"Biochem Pharmacol"},{"key":"1595_CR103","first-page":"110288","volume":"369","author":"MA Rabie","year":"2022","unstructured":"Rabie MA, Ibrahim HI, Nassar NN, Atef RM (2022) Adenosine A 1 receptor agonist, N6-cyclohexyladenosine, attenuates Huntington\u2019s disease via stimulation of TrKB\/PI3K\/Akt\/CREB\/BDNF pathway in 3-nitropropionic acid rat model. Chem Biol Interact 369:110288","journal-title":"Chem Biol Interact"},{"key":"1595_CR104","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/epi4.12242","volume":"3","author":"T Ravizza","year":"2018","unstructured":"Ravizza T, Vezzani A (2018) Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies. Epilepsia Open 3:133\u2013142","journal-title":"Epilepsia Open"},{"key":"1595_CR105","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.bbi.2017.10.008","volume":"72","author":"T Ravizza","year":"2018","unstructured":"Ravizza T, Terrone G, Salamone A, Frigerio F, Balosso S, Antoine DJ, Vezzani A (2018) High mobility group box 1 is a novel pathogenic factor and a mechanistic biomarker for epilepsy. Brain Behav Immun 72:14\u201321","journal-title":"Brain Behav Immun"},{"key":"1595_CR106","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3390\/brainsci13071076","volume":"13","author":"K Razali","year":"2023","unstructured":"Razali K, Mohd Nasir MH, Kumar J, Mohamed WM (2023) Mitophagy: a bridge linking HMGB1 and Parkinson\u2019s disease using adult zebrafish as a model organism. Brain Sci 13:1076","journal-title":"Brain Sci"},{"key":"1595_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115234","volume":"292","author":"Q Ren","year":"2022","unstructured":"Ren Q, Jiang X, Paudel YN, Gao X, Gao D, Zhang P, Sheng W, Shang X, Liu K, Zhang X (2022) Co-treatment with natural HMGB1 inhibitor Glycyrrhizin exerts neuroprotection and reverses Parkinson\u2019s disease like pathology in Zebrafish. J Ethnopharmacol 292:115234","journal-title":"J Ethnopharmacol"},{"key":"1595_CR108","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s10020-023-00717-3","volume":"29","author":"W Ren","year":"2023","unstructured":"Ren W, Zhao L, Sun Y, Wang X, Shi X (2023) HMGB1 and toll-like receptors: potential therapeutic targets in autoimmune diseases. Mol Med 29:117","journal-title":"Mol Med"},{"key":"1595_CR109","doi-asserted-by":"publisher","first-page":"380","DOI":"10.3389\/fncel.2019.00380","volume":"13","author":"G Rosciszewski","year":"2019","unstructured":"Rosciszewski G, Cadena V, Auzmendi J, Cieri MB, Lukin J, Rossi AR, Murta V, Villarreal A, Rein\u00e9s A, Gomes FC (2019) Detrimental effects of HMGB-1 require microglial-astroglial interaction: implications for the status epilepticus-induced neuroinflammation. Front Cell Neurosci 13:380","journal-title":"Front Cell Neurosci"},{"key":"1595_CR110","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/nrneurol.2014.24","volume":"10","author":"CA Ross","year":"2014","unstructured":"Ross CA, Aylward EH, Wild EJ, Langbehn DR, Long JD, Warner JH, Scahill RI, Leavitt BR, Stout JC, Paulsen JS, Reilmann R, Unschuld PG, Wexler A, Margolis RL, Tabrizi SJ (2014) Huntington disease: natural history, biomarkers and prospects for therapeutics. Nat Rev Neurol 10:204\u2013216","journal-title":"Nat Rev Neurol"},{"key":"1595_CR111","doi-asserted-by":"publisher","first-page":"32960","DOI":"10.1038\/srep32960","volume":"6","author":"A Rouhiainen","year":"2016","unstructured":"Rouhiainen A, Zhao X, Vanttola P, Qian K, Kulesskiy E, Kuja-Panula J, Gransalke K, Gronholm M, Unni E, Meistrich M, Tian L, Auvinen P, Rauvala H (2016) HMGB4 is expressed by neuronal cells and affects the expression of genes involved in neural differentiation. Sci Rep 6:32960","journal-title":"Sci Rep"},{"key":"1595_CR112","doi-asserted-by":"publisher","first-page":"800","DOI":"10.3390\/biom11060800","volume":"11","author":"H Salo","year":"2021","unstructured":"Salo H, Qu H, Mitsiou D, Aucott H, Han J, Zhang X, Aulin C, Erlandsson Harris H (2021) Disulfide and fully reduced HMGB1 induce different macrophage polarization and migration patterns. Biomolecules 11:800","journal-title":"Biomolecules"},{"key":"1595_CR113","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.nbd.2016.02.018","volume":"91","author":"M Santoro","year":"2016","unstructured":"Santoro M, Maetzler W, Stathakos P, Martin HL, Hobert MA, Rattay TW, Gasser T, Forrester JV, Berg D, Tracey KJ, Riedel G, Teismann P (2016) In-vivo evidence that high mobility group box 1 exerts deleterious effects in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model and Parkinson\u2019s disease which can be attenuated by glycyrrhizin. Neurobiol Dis 91:59\u201368","journal-title":"Neurobiol Dis"},{"issue":"Pt 1","key":"1595_CR114","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.expneurol.2015.11.003","volume":"275","author":"T Sasaki","year":"2016","unstructured":"Sasaki T, Liu K, Agari T, Yasuhara T, Morimoto J, Okazaki M, Takeuchi H, Toyoshima A, Sasada S, Shinko A, Kondo A, Kameda M, Miyazaki I, Asanuma M, Borlongan CV, Nishibori M, Date I (2016) Anti-high mobility group box 1 antibody exerts neuroprotection in a rat model of Parkinson\u2019s disease. Exp Neurol 275(Pt 1):220\u2013231","journal-title":"Exp Neurol"},{"key":"1595_CR115","doi-asserted-by":"publisher","DOI":"10.15252\/msb.20209760","volume":"17","author":"K Sofiadis","year":"2021","unstructured":"Sofiadis K, Josipovic N, Nikolic M, Kargapolova Y, Ubelmesser N, Varamogianni-Mamatsi V, Zirkel A, Papadionysiou I, Loughran G, Keane J, Michel A, Gusmao EG, Becker C, Altmuller J, Georgomanolis T, Mizi A, Papantonis A (2021) HMGB1 coordinates SASP-related chromatin folding and RNA homeostasis on the path to senescence. Mol Syst Biol 17:e9760","journal-title":"Mol Syst Biol"},{"key":"1595_CR116","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1074\/jbc.RA117.001440","volume":"294","author":"S Son","year":"2019","unstructured":"Son S, Bowie LE, Maiuri T, Hung CL, Desmond CR, Xia J, Truant R (2019a) High-mobility group box 1 links sensing of reactive oxygen species by Huntingtin to its nuclear entry. J Biol Chem 294:1915\u20131923","journal-title":"J Biol Chem"},{"key":"1595_CR117","doi-asserted-by":"publisher","first-page":"6763","DOI":"10.1073\/pnas.100110097","volume":"97","author":"JS Steffan","year":"2000","unstructured":"Steffan JS, Kazantsev A, Spasic-Boskovic O, Greenwald M, Zhu YZ, Gohler H, Wanker EE, Bates GP, Housman DE, Thompson LM (2000) The Huntington\u2019s disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc Natl Acad Sci U S A 97:6763\u20136768","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1595_CR118","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.3389\/fimmu.2018.01518","volume":"9","author":"Y Sun","year":"2018","unstructured":"Sun Y, Chen H, Dai J, Wan Z, Xiong P, Xu Y, Han Z, Chai W, Gong F, Zheng F (2018) Glycyrrhizin protects mice against experimental autoimmune encephalomyelitis by inhibiting high-mobility group box 1 (HMGB1) expression and neuronal HMGB1 release. Front Immunol 9:1518","journal-title":"Front Immunol"},{"key":"1595_CR119","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.bbi.2021.06.011","volume":"97","author":"TA Szabo-Pardi","year":"2021","unstructured":"Szabo-Pardi TA, Barron LR, Lenert ME, Burton MD (2021) Sensory Neuron TLR4 mediates the development of nerve-injury induced mechanical hypersensitivity in female mice. Brain Behav Immun 97:42\u201360","journal-title":"Brain Behav Immun"},{"key":"1595_CR120","doi-asserted-by":"publisher","first-page":"73","DOI":"10.2147\/CIA.S159148","volume":"14","author":"JP Tavana","year":"2019","unstructured":"Tavana JP, Rosene M, Jensen NO, Ridge PG, Kauwe JS, Karch CM (2019) RAB10: an Alzheimer\u2019s disease resilience locus and potential drug target. Clin Interv Aging 14:73\u201379","journal-title":"Clin Interv Aging"},{"key":"1595_CR121","doi-asserted-by":"publisher","first-page":"849","DOI":"10.3390\/cells11050849","volume":"11","author":"S Taverna","year":"2022","unstructured":"Taverna S, Tonacci A, Ferraro M, Cammarata G, Cuttitta G, Bucchieri S, Pace E, Gangemi S (2022) High mobility group box 1: biological functions and relevance in oxidative stress related chronic diseases. Cells 11:849","journal-title":"Cells"},{"key":"1595_CR122","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10753-022-01721-1","volume":"46","author":"S Thakur","year":"2023","unstructured":"Thakur S, Dhapola R, Sarma P, Medhi B, Reddy DH (2023) Neuroinflammation in Alzheimer\u2019s disease: current progress in molecular signaling and therapeutics. Inflammation 46:1\u201317","journal-title":"Inflammation"},{"key":"1595_CR123","doi-asserted-by":"publisher","DOI":"10.22541\/au.166126875.56478352\/v1","author":"Y Tian","year":"2022","unstructured":"Tian Y, Jiang L, Zhang S, Cao Y, Liu F, Xia L, Su Z (2022) HMGB1 a box binds to CXCR4 to inhibit HMGB1\/CXCL12 mediating macrophage and T cell infiltration and prevents neuronal damage in Parkinson\u2019s disease. Authorea Preprints. https:\/\/doi.org\/10.22541\/au.166126875.56478352\/v1","journal-title":"Authorea Preprints"},{"key":"1595_CR124","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1084\/jem.20160217","volume":"215","author":"M Tirone","year":"2018","unstructured":"Tirone M, Tran NL, Ceriotti C, Gorzanelli A, Canepari M, Bottinelli R, Raucci A, Di Maggio S, Santiago C, Mellado M (2018) High mobility group box 1 orchestrates tissue regeneration via CXCR4. J Exp Med 215:303\u2013318","journal-title":"J Exp Med"},{"key":"1595_CR125","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.chembiol.2021.04.003","volume":"28","author":"F T\u00fcrker","year":"2021","unstructured":"T\u00fcrker F, Cook EK, Margolis SS (2021) The proteasome and its role in the nervous system. Cell Chem Biol 28:903\u2013917","journal-title":"Cell Chem Biol"},{"key":"1595_CR126","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1007\/s11064-023-03868-1","volume":"48","author":"S Upadhayay","year":"2023","unstructured":"Upadhayay S, Yedke NG, Rahi V, Singh S, Kumar S, Arora A, Chandolia P, Kaur P, Kumar M, Koshal P, Jamwal S, Kumar P (2023) An overview of the pathophysiological mechanisms of 3-nitropropionic acid (3-NPA) as a neurotoxin in a Huntington\u2019s disease model and its relevance to drug discovery and development. Neurochem Res 48:1631\u20131647","journal-title":"Neurochem Res"},{"key":"1595_CR127","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cegh.2016.07.003","volume":"5","author":"AK Verma","year":"2017","unstructured":"Verma AK, Raj J, Sharma V, Singh TB, Srivastava S, Srivastava R (2017) Epidemiology and associated risk factors of Parkinson\u2019s disease among the north Indian population. Clin Epidemiol Global Health 5:8\u201313","journal-title":"Clin Epidemiol Global Health"},{"key":"1595_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/ar3450","volume":"13","author":"H W\u00e4h\u00e4maa","year":"2011","unstructured":"W\u00e4h\u00e4maa H, Schierbeck H, Hreggvidsdottir HS, Palmblad K, Aveberger A-C, Andersson U, Harris HE (2011) High mobility group box protein 1 in complex with lipopolysaccharide or IL-1 promotes an increased inflammatory phenotype in synovial fibroblasts. Arthritis Res Ther 13:1\u201312","journal-title":"Arthritis Res Ther"},{"key":"1595_CR129","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3389\/fncel.2020.00129","volume":"14","author":"CC Walton","year":"2020","unstructured":"Walton CC, Begelman D, Nguyen W, Andersen JK (2020) Senescence as an amyloid cascade: the amyloid senescence hypothesis. Front Cell Neurosci 14:129","journal-title":"Front Cell Neurosci"},{"key":"1595_CR130","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3233\/JHD-200426","volume":"10","author":"VC Wheeler","year":"2021","unstructured":"Wheeler VC, Dion V (2021) Modifiers of CAG\/CTG repeat instability: insights from mammalian models. Journal of Huntington\u2019s Disease 10:123\u2013148","journal-title":"Journal of Huntington\u2019s Disease"},{"key":"1595_CR131","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1093\/brain\/awab103","volume":"144","author":"GP Williams","year":"2021","unstructured":"Williams GP, Schonhoff AM, Jurkuvenaite A, Gallups NJ, Standaert DG, Harms AS (2021) CD4 T cells mediate brain inflammation and neurodegeneration in a mouse model of Parkinson\u2019s disease. Brain 144:2047\u20132059","journal-title":"Brain"},{"key":"1595_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113561","volume":"172","author":"J Wu","year":"2023","unstructured":"Wu J, Hao Z, Wang Y, Yan D, Meng J, Ma H (2023) Melatonin alleviates BDE-209-induced cognitive impairment and hippocampal neuroinflammation by modulating microglia polarization via SIRT1-mediated HMGB1\/TLR4\/NF-\u03baB pathway. Food Chem Toxicol 172:113561","journal-title":"Food Chem Toxicol"},{"key":"1595_CR133","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.695808","volume":"13","author":"X Xiao","year":"2021","unstructured":"Xiao X, Liu H, Liu X, Zhang W, Zhang S, Jiao B (2021) APP, PSEN1, and PSEN2 variants in Alzheimer\u2019s disease: systematic re-evaluation according to ACMG guidelines. Front Aging Neurosci 13:695808","journal-title":"Front Aging Neurosci"},{"key":"1595_CR134","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang H, Wang H, Ju Z, Ragab AA, Lundb\u00e4ck P, Long W, Valdes-Ferrer SI, He M, Pribis JP, Li J (2015) MD-2 is required for disulfide HMGB1\u2013dependent TLR4 signaling. J Exp Med 212:5\u201314","journal-title":"J Exp Med"},{"key":"1595_CR135","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.948","volume":"8","author":"Y Yang","year":"2018","unstructured":"Yang Y, Han C, Guo L, Guan Q (2018) High expression of the HMGB1\u2013TLR4 axis and its downstream signaling factors in patients with Parkinson\u2019s disease and the relationship of pathological staging. Brain and Behavior 8:e00948","journal-title":"Brain and Behavior"},{"key":"1595_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s10020-021-00307-1","volume":"27","author":"H Yang","year":"2021","unstructured":"Yang H, Lundb\u00e4ck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ (2021a) Redox modifications of cysteine residues regulate the cytokine activity of HMGB1. Mol Med 27:1\u20137","journal-title":"Mol Med"},{"key":"1595_CR137","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102034118","volume":"118","author":"H Yang","year":"2021","unstructured":"Yang H, Zeng Q, Silverman HA, Gunasekaran M, George SJ, Devarajan A, Addorisio ME, Li J, Tsaava T, Shah V, Billiar TR, Wang H, Brines M, Andersson U, Pavlov VA, Chang EH, Chavan SS, Tracey KJ (2021b) HMGB1 released from nociceptors mediates inflammation. Proc Natl Acad Sci U S A 118:e2102034118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1595_CR138","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109504","volume":"114","author":"W Yang","year":"2023","unstructured":"Yang W, Xu Q-Q, Yuan Q, Xian Y-F, Lin Z-X (2023) Sulforaphene, a CDK5 inhibitor, attenuates cognitive deficits in a transgenic mouse model of Alzheimer\u2019s disease via reducing A\u03b2 deposition, tau hyperphosphorylation and synaptic dysfunction. Int Immunopharmacol 114:109504","journal-title":"Int Immunopharmacol"},{"key":"1595_CR139","doi-asserted-by":"publisher","DOI":"10.1590\/fst.122322","author":"X Ye","year":"2023","unstructured":"Ye X, Wu Y, Chen Q, Song H, Cheng J (2023) Effect of lipoxin A 4 methyl ester from arachidonic acid on JAK2\/STAT3 pathway after cerebral ischemia-reperfusion injury. Food Sci Technol. https:\/\/doi.org\/10.1590\/fst.122322","journal-title":"Food Sci Technol"},{"key":"1595_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13045-020-00920-3","volume":"13","author":"S Yuan","year":"2020","unstructured":"Yuan S, Liu Z, Xu Z, Liu J, Zhang J (2020) High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignancies. J Hematol Oncol 13:1\u201319","journal-title":"J Hematol Oncol"},{"key":"1595_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.890015","volume":"17","author":"N Zaghloul","year":"2023","unstructured":"Zaghloul N, Cohen NS, Ayasolla KR, Li HL, Kurepa D, Ahmed MN (2023) Galantamine ameliorates hyperoxia-induced brain injury in neonatal mice. Front Neurosci 17:890015","journal-title":"Front Neurosci"},{"key":"1595_CR142","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1002\/ar.21116","volume":"293","author":"SM Zakhary","year":"2010","unstructured":"Zakhary SM, Ayubcha D, Dileo JN, Jose R, Leheste JR, Horowitz JM, Torres G (2010) Distribution analysis of deacetylase SIRT1 in rodent and human nervous systems. Anat Rec (Hoboken) 293:1024\u20131032","journal-title":"Anat Rec (Hoboken)"},{"key":"1595_CR143","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.bcp.2015.08.109","volume":"98","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Karki R, Igwe OJ (2015) Toll-like receptor 4 signaling: a common pathway for interactions between prooxidants and extracellular disulfide high mobility group box 1 (HMGB1) protein-coupled activation. Biochem Pharmacol 98:132\u2013143","journal-title":"Biochem Pharmacol"},{"key":"1595_CR144","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3233\/JAD-191110","volume":"74","author":"J Zhang","year":"2020","unstructured":"Zhang J, Hua X-f, Gu J, Chen F, Gu J, Gong C-X, Liu F, Dai C-L (2020a) High mobility group box 1 ameliorates cognitive impairment in the 3\u00d7 Tg-AD mouse model. J Alzheimers Dis 74:851\u2013864","journal-title":"J Alzheimers Dis"},{"key":"1595_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172847","volume":"867","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Anoopkumar-Dukie S, Arora D, Davey AK (2020b) Review of the anti-inflammatory effect of SIRT1 and SIRT2 modulators on neurodegenerative diseases. Eur J Pharmacol 867:172847","journal-title":"Eur J Pharmacol"},{"key":"1595_CR146","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, Xiao D, Mao Q, Xia H (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8:267","journal-title":"Signal Transduct Target Ther"},{"key":"1595_CR147","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1074\/jbc.M112.413575","volume":"288","author":"Z Zheng","year":"2013","unstructured":"Zheng Z, Li A, Holmes BB, Marasa JC, Diamond MI (2013) An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem 288:6063\u20136071","journal-title":"J Biol Chem"},{"key":"1595_CR148","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-016-0094-3","volume":"11","author":"Y Zhou","year":"2016","unstructured":"Zhou Y, Lu M, Du R-H, Qiao C, Jiang C-Y, Zhang K-Z, Ding J-H, Hu G (2016) MicroRNA-7 targets nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson\u2019s disease. Mol Neurodegener 11:1\u201315","journal-title":"Mol Neurodegener"},{"key":"1595_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.172857","volume":"869","author":"Z Zhou","year":"2020","unstructured":"Zhou Z, Hou J, Mo Y, Ren M, Yang G, Qu Z, Hu Y (2020) Geniposidic acid ameliorates spatial learning and memory deficits and alleviates neuroinflammation via inhibiting HMGB-1 and downregulating TLR4\/2 signaling pathway in APP\/PS1 mice. Eur J Pharmacol 869:172857","journal-title":"Eur J Pharmacol"},{"key":"1595_CR150","doi-asserted-by":"publisher","first-page":"2701","DOI":"10.1016\/j.apsb.2023.03.011","volume":"13","author":"Q Zhu","year":"2023","unstructured":"Zhu Q, Song J, Chen J-Y, Yuan Z, Liu L, Xie L-M, Liao Q, Richard DY, Chen X, Yan Y (2023) Corynoxine B targets at HMGB1\/2 to enhance autophagy for \u03b1-synuclein clearance in fly and rodent models of Parkinson\u2019s disease. Acta Pharmaceutica Sinica B 13:2701\u20132714","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1595_CR151","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/ng1219","volume":"35","author":"C Zuccato","year":"2003","unstructured":"Zuccato C, Tartari M, Crotti A, Goffredo D, Valenza M, Conti L, Cataudella T, Leavitt BR, Hayden MR, Timmusk T, Rigamonti D, Cattaneo E (2003) Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat Genet 35:76\u201383","journal-title":"Nat Genet"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-024-01595-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-024-01595-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:40:05Z","timestamp":1740109205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-024-01595-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,15]]},"references-count":151,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["1595"],"URL":"https:\/\/doi.org\/10.1007\/s10787-024-01595-9","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,15]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare that they did not have any financial or personal interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}